Lazard Asset Management
KURA icon

Lazard Asset Management’s Kura Oncology KURA Stock Holding History

Lazard Asset Management’s Portfolio KURA Stock Details KURA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-10,423
Closed -$108K – 1989
2025
Q4 		$108K Hold
10,423
– – ﹤0.01% 1735
2025
Q3 		$92.2K Buy
10,423
+7,189
+222% +$51.2K ﹤0.01% 1695
2025
Q2 		$18K Sell
3,234
-8,517
-72% -$52.2K ﹤0.01% 2133
2025
Q1 		$77K Buy
+11,751
New +$91.6K ﹤0.01% 1882
2018
Q2 		– Sell
-44,592
Closed -$836K – 1087
2018
Q1 		$836K Buy
44,592
+9,523
+27% +$185K ﹤0.01% 729
2017
Q4 		$536K Buy
+35,069
New +$517K ﹤0.01% 768

Other funds holding KURA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SCM
Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
PM
Prosight Management Dallas, Texas $580M AUM 29.81% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Lazard Asset Management's KURA Position: Q1 2026 in Review

Lazard Asset Management sold out of Kura Oncology (KURA) in Q1 2026, closing a stake of 10,423 shares — an estimated $108K sold.

Lazard Asset Management first reported a position in KURA in Q4 2017 and held it in 6 quarters. The position peaked at $836K in Q1 2018. 222 funds tracked by Wall St. Rank hold KURA as of Q1 2026.

  • Lazard Asset Management reported no remaining Kura Oncology position as of Q1 2026 after selling out during the quarter.
  • Lazard Asset Management sold 10,423 Kura Oncology shares in Q1 2026, an estimated $108K.
  • Lazard Asset Management first reported a position in Kura Oncology in Q4 2017 and held it in 6 quarters.
  • Lazard Asset Management's Kura Oncology position peaked at $836K in Q1 2018.
  • 222 funds tracked by Wall St. Rank held Kura Oncology as of Q1 2026.

Based on Lazard Asset Management's 13F filing for Q1 2026, filed 15 May 2026.